Clinical trial
A Phase 1b, Randomized, Single Blind Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis
NCT00244647 is registered in ClinicalTrials.gov with Sarepta Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1b, Randomized, Single Blind Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis
- Lead sponsor
- Sarepta Therapeutics, Inc.
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- August 31, 2003
- Completion date
- Not reported
- Enrollment
- 40
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, coronary stent restenosis